• Small solute clearances were compared between two groups of patients on continuous ambulatory peritoneal dialysis (CAPD), an underweight group with a ratio of actual-to-ideal weight (W/IW) less than 0.9 and a normalweight group with W/IW between 0.9 and 1.2 at the first clearance study after initiation of CAPD. Adequate clearance levels were set according to the K/DOQI guidelines. Duration of follow-up during CAPD and time on CAPD until the first clearance study was similar in the two groups. Initial weekly Kt/V urea and creatinine clearance also were similar. Kt/V urea values were adequate in 41.8% of the underweight subjects and 41.0% of the normal-weight subjects (not significant). Corresponding percentages for creatinine clearance were 36.4% and 39.7% (not significant). Serum creatinine and albumin concentration, creatinine excretion, and lean body mass estimated from creatinine kinetics were lower in the underweight group. Weight measurements from initiation of CAPD were available in 37 underweight patients. At initiation of CAPD, 31 subjects had W/IW less than 0.9, and 6 subjects had W/IW greater than 0.9. Chronic catabolic illness was present at CAPD initiation in 19 patients. Among the 37 patients, 17 lost weight and 6 gained weight during the course of CAPD. Compared with patients who lost weight, those who gained weight were younger (35.6 ؎ 9.3 years old versus 58.4 ؎ 15.0 years old; P ‫؍‬ 0.0069) and had a higher percent of women (80.0% versus 11.8%; P ‫؍‬ 0.0093), higher initial weekly Kt/V urea (2.58 ؎ 0.50 versus 1.91 ؎ 0.24; P ‫؍‬ 0.0087), and a higher percent of adequate Kt/V urea (80.0% versus 11.8%; P ‫؍‬ 0.0093). Small solute clearances do not differ between underweight CAPD patients and normal-weight CAPD patients. Underweight CAPD patients usually start CAPD with a weight deficit and have associated catabolic illnesses. Catabolic illness is the sole cause of weight deficit in 40% of the underweight CAPD patients and is present in the remaining 60%. The role of inadequate clearances in the development of weight deficit in CAPD populations is difficult to assess. It seems, however, that adequate Kt/V urea may be necessary for weight gain in underweight CAPD patients.
I
N HEMODIALYSIS PATIENTS, weight deficit is associated with high mortality rates, whereas obesity is associated with low mortality rates. 1, 2 The survival advantage of excess weight is seen despite lower urea clearance delivered to obese patients mostly because of prescription constraints. 3, 4 A report suggested that obesity also might be a predictor of long survival in peritoneal dialysis patients. 5 Weight deficit seems to have adverse effects on survival of peritoneal dialysis populations. 6, 7 Patients on continuous ambulatory peritoneal dialysis (CAPD) are subject to catabolic illness, which also causes weight deficit in the general population. In addition, some causes of weight deficit may be seen exclusively in peritoneal dialysis. One of the causes of weight deficit exclusive to peritoneal dialysis is inadequate clearance. In a reanalysis of a multicenter study of malnutrition in CAPD, 8 Jones 9 suggested that low small solute clearances in anuric subjects lead to uremic anorexia and weight loss.
The purpose of the present study was to analyze the association between small solute (urea and creatinine) clearances and weight deficit in peritoneal dialysis. We tested the following hypotheses: (1) Normalized small solute clearances do not differ between underweight and normalweight patients at the first clearance study performed after initiation of CAPD. ( 2) The fractions of underweight and normal-weight CAPD patients receiving adequate clearances at the first clearance study do not differ. ( 3) The percents of underweight and normal-weight CAPD patients with anuria at the first clearance study do not differ. We also searched for evidence of other conditions causing weight loss (catabolic illness) in the underweight patients.
METHODS
The study included 735 patients on CAPD with four daily exchanges and 2-L fill volume. These patients started CAPD between 1988 and 1999 and had one or more clearance studies during the course of CAPD. Among these patients, we identified an underweight and a normal-weight group using body weights measured at the first clearance study after initiation of CAPD. In populations, subjects are classified as underweight, normal weight, or overweight by height/ weight indices, including body mass index (BMI) and deviation of body weight from ideal weight (IW). 10, 11 Classification of obesity by BMI does not take into account gender differences (women tend to be lighter than men with the same height, skeletal frame, and body fat). For this reason, we classified the subjects of this study as underweight, normal weight, or obese by the ratio of weight (W) to ideal weight (W/IW). Subjects with W/IW less than 0.9 were classified as underweight, subjects with W/IW between 0.9 and 1.2 were classified as having normal weight, and subjects with W/IW greater than 1.2 were classified as obese. 11 Discrepancies of classification of peritoneal dialysis patients as underweight by BMI and W/IW are infrequent. 12 Another study of nutrition in peritoneal dialysis also classified underweight as W/IW less than or equal 0.9. 13 IW was calculated by the Hamwi formula 14 converted to the metric system 15 assuming medium skeletal frame for all patients. The following formulae were used: IW Women ϭ 45.45 ϩ 0.895͑H Ϫ 152.4͒
(1)
where IW is in kg and height (H) is in cm. Clearance studies were performed using standard techniques. [15] [16] [17] The Watson formulae 18 were used to estimate body water (V) for Kt/V urea calculations, and the Dubois formula 19 was used to estimate body surface area (BSA) for creatinine clearance calculations. Renal creatinine clearance was calculated as the average of the renal urea and creatinine clearances. 20 The method for measuring creatinine concentration in body fluids does not receive interference from glucose.
Protein nitrogen appearance equivalent (PNA) was estimated by the method of Randerson 21 and was normalized for body size (nPNA) by standard weight. 16, 22 For each subject, standard weight (V/0.58) was computed using actual and ideal weight. Lean body mass (LBM) was estimated from creatinine kinetics 23 and was normalized to actual weight (LBM/W) and ideal weight (LBM/IW).
Continuous variables are reported as mean Ϯ SD. Patients with weight deficit (W/IW Ͻ0.9, group I) were compared with patients with normal body weight (W/IW 0.9 to 1.2, group II). Comparison was done by the two-tailed Student t test for continuous variables and the chi-square for categorical variables. The categorical variables compared included the fraction of the patients in the underweight and normalweight groups who had actual clearances greater than the K/DOQI standards. 24 In the normal-weight group, adequate weekly Kt/V urea was set at 2.0, and adequate weekly creatinine clearance was set at 60 L/1.73 m 2 . The same adequate creatinine clearance value was set for all normal-weight subjects because several patients did not have formal studies of their peritoneal transport characteristics. For underweight individuals, the K/DOQI standards are as follows: weekly Kt/V urea 2.0 ϫ V desired /V actual , where V desired is the value calculated by the Watson formulae using ideal instead of normal weight; weekly creatinine clearance 60 ϫ BSA desired /BSA actual , where BSA desired is calculated by the Dubois formula using ideal instead of actual weight. 24 We subdivided the patients in this study into four subgroups: underweight subjects with adequate Kt/V urea (subgroup IA), underweight subjects with inadequate Kt/V urea (subgroup IB), normal-weight subjects with adequate Kt/V urea (subgroup IIA), and normal-weight subjects with inadequate Kt/V urea (subgroup IIB) at the first clearance study after CAPD initiation. We compared subgroup IA with subgroup IIA, subgroup IB with subgroup IIB, and subgroup IA with subgroup IB.
Finally, we traced weight measurements of many underweight individuals to the initiation of CAPD and to a period preceding the initiation of CAPD by 6 to 18 months. Underweight patients who lost weight were compared with underweight individuals who gained weight during the course of CAPD. The distribution of continuous variables in these subgroups did not follow a normal pattern. We used the Mann-Whitney U test to compare these variables. Categorical variables were compared between the subgroups by Fisher's exact test.
RESULTS
The underweight group (group I) contained 55 subjects (7.5% of the 735 patients in the whole set). These subjects had 77 clearance studies. The normal-weight group (group II) contained 378 individuals (51.4% of the total) who had 425 clearance studies. Table 1 shows the comparison of demographic and anthropometric variables. The percent of women and diabetic subjects and the follow-up during CAPD did not differ between the underweight and normal-weight groups. Duration of CAPD until the first clearance study did not differ between the groups. The underweight group was younger, lighter, and marginally taller than the normal-weight group. Of the 55 subjects in the underweight group, 53 had BMI values less than 20 kg/m 2 . Table 2 shows nutritional indices at the first clearance study after initiation of CAPD. Blood urea nitrogen, total (in urine plus dialysate) urea nitrogen excretion, and PNA did not differ between the groups. Serum albumin, serum creatinine, total creatinine excretion, and LBM were lower in the underweight group. The normalizing size indicator affected the comparison of nPNA and LBM/W. When the normalizing size indicator was based on actual weight, neither nPNA nor LBM/W differed between the groups. When the normalizing size indicator was based on ideal weight, however, the values of these parameters in the underweight group were lower than the corresponding values in the normal-weight group. Table 3 shows clearance determinants and weekly clearances at the first clearance study.
Dialysate drain volume was marginally lower in the normal-weight group. Urine volume, percent of subjects with anuria, D/P urea and creatinine, normalized clearances, and percent of subjects with adequate clearances did not differ between the groups, despite the fact that the K/DOQI standard is substantially higher in underweight than normal-weight CAPD patients for Kt/V urea and creatinine clearance. A peritoneal equilibration test was performed within 1 year of the clearance studies in 46 subjects in the underweight group and 302 subjects in the normalweight group. High peritoneal transport was found in 11 underweight subjects (23.9%) and 32 normal-weight subjects (10.6%). The difference in frequencies of high transport was significant (P Ͻ 0.05). Table 4 shows nutrition indices differing between underweight patients with adequate Kt/V urea (subgroup IA) and normal-weight patients with adequate Kt/V urea (subgroup IIA). Weekly Kt/V urea and creatinine clearance were higher in subgroup IA. The difference disappeared when V and BSA, used for the calculation of Kt/V urea and creatinine clearance, were calculated with the use of ideal, rather than actual, weight. In addition, neither the raw clearances of urea nor the raw clearances of creatinine differed between subgroups IA and IIA. Patients in subgroup IA were younger and had lower serum albumin than patients in subgroup IIA. LBM normalized to actual weight was larger in subgroup IA, whereas LBM normalized to ideal weight was larger in subgroup IIA. In addition to the difference shown in Table 4 , subgroup IA had significantly lower weight, BMI, BSA, and V Watson and marginally (0.05 Ͻ P Ͻ 0.10) lower serum creatinine, creatinine excretion, LBM, and nPNA IW than subgroup IIA. No differences between subgroups IA and IIA were found in gender, frequency of diabetes, total duration of CAPD, duration of CAPD until the first clearance study, blood urea nitrogen, urine volume and renal clearances, dialysate drain volume, ideal weight, PNA, and nPNA W . Table 5 shows nutrition indices differing between underweight patients with inadequate Kt/V Monthly weight measurements from initiation of CAPD were found in 37 underweight patients. At initiation of CAPD, 31 subjects had W/IW less than 0.9, and 6 subjects had W/IW between 0.9 and 1.0. Among these 37 subjects, 28 also had documented weight measurements for 6 to 18 months preceding the initiation of CAPD. Progressive weight loss before initiation of CAPD was noted in 20 of the 28 subjects. Nineteen of these subjects had catabolic illnesses, including type 1 diabetes mellitus with severe gastroparesis (5 subjects); end-stage heart failure (4 subjects); disseminated malignancy (4 subjects [2 with prostatic carcinoma, 1 with lung carcinoma, 1 with myeloma]); respiratory failure associated with old cavitary tuberculosis or extensive interstitial pulmonary fibrosis (3 subjects); alcoholism, cocaine abuse, hepatitis C, and advanced cirrhosis (1 subject); systemic lupus erythematosus with multiple organ involvement (1 patient); and renal transplant failure after 18 years of ESRD treatment (1 patient). We found no reports of the level of renal function at initiation of CAPD.
Among the 37 underweight subjects with weight documentation throughout the CAPD period, 15 had no significant weight change (Յ1 kg) during the CAPD period; 17, including the 6 subjects with initial W/IW greater than 0.9, had significant weight loss (Ͼ1 kg); and 5 subjects had significant weight gain (Ͼ1 kg) from the initiation of CAPD to the end of the observation period. At the first clearance study, the 15 patients without significant weight loss had a weekly Kt/V urea of 2.08 Ϯ 0.45 (K/DOQI standard, 2.22 Ϯ 0.10), with 6 subjects having actual greater than adequate Kt/V urea and weekly creatinine clearance 73.1 Ϯ 35.4 L/1.73 m 2 (K/ DOQI standard, 66.2 Ϯ 1.7 L/1.73 m 2 ) and 8 subjects having actual greater than adequate creatinine clearance. Table 7 shows the comparison of the underweight patients who lost weight and the underweight patients who gained weight during the CAPD period. The group that lost weight had older age, lower percent of women, lower Kt/V urea, and lower percent of adequate Kt/V urea in the first clearance study than the group that gained weight. Total duration of CAPD, percent of diabetic subjects, percent of anuric subjects, creatinine clearance, and percent of adequate creatinine clearance values did not differ between the groups. The group that lost weight had a marginally higher W/IW ratio at the first clearance study and marginally shorter duration be- tween the first clearance study and the last nutrition evaluation.
All five subjects who gained weight were alive at the end of the observation period and had repeated clearance values greater than the adequacy values. Among the patients in the group that lost weight, 10 died within 8 months of the first clearance study. Weight loss continued during the follow-up period in all 10 patients. Six subjects died from catabolic illness associated with the weight loss. Four subjects died with accelerated weight loss and worsening of hypoalbuminemia shortly after episodes of persistent peritonitis, two from fungal infections and 1 each from Staphylococcus aureus and Pseudomonas aeruginosa. One subject with repeated S aureus exit site infection and peritonitis episodes was transferred to hemodialysis and 2 years later is alive with a small weight gain. The remaining six subjects were alive and had a second clearance study. Kt/V urea remained below adequacy targets in all six subjects, whereas creatinine clearance was above the adequate level in two of these subjects.
DISCUSSION
Nutritional aspects of peritoneal dialysis have been investigated extensively. [25] [26] [27] [28] [29] [30] Body weight as an index of nutrition has received less attention. It is known, however, that weight gain is associated with long survival, 30 whereas weight loss in the course of CAPD is associated with a high death rate. 31 Large body weight is associated with high serum albumin levels in peritoneal dialysis. 32 Despite these associations, multivariate analyses of predictors of survival in peritoneal dialysis often fail to include body weight, or an index of obesity, among the variables tested, 26, 33 and there is a paucity of studies analyzing weight deficit in peritoneal dialysis. 13 The prevalence of weight deficit in general populations depends on the cutoff value of the height-weight index chosen to classify the degree of obesity. In the Third National Health Nutrition Examination Survey (NHANES III), BMI less than 19.0 kg/m 2 was found in 1.6% of the men and 5.7% of the women. 34 In a Western European general population, BMI less than 18.5 kg/m 2 was found in 1.4% of the men and 3.3% of the women. 35 The prevalence of underweight may vary in specific populations. In a study analyzing degree of obesity in 115,195 American nurses, 12.8% had BMI less than 19.0 kg/m 2 . 36 Underweight was defined as W/IW less than or equal to 0.9 in a study analyzing nutrition in peritoneal dialysis patients 13 and in the present study. BMI values corresponding to a W/IW of 0.9 are18.8 kg/m 2 , with a 95% confidence interval of 15.7 to 21.8 kg/m 2 , in women and 21.2 kg/m 2 , with a 95% confidence interval of 19.2 to 23.1 kg/m 2 , in men on peritoneal dialysis. 12 Approximately 7% of the peritoneal dialysis patients in the United States have BMI less than 20 kg/m 2 . 37 In these patients, weight deficit may result from catabolic conditions present either in the general and peritoneal dialysis populations alike or only in the peritoneal dialysis population. Among the latter, inadequate dialysis and severe peritoneal catheter-related infections have received some attention. Jones 9 noted that weight deficit was more common in CAPD patients who lost residual renal function but did not have a change in their dialysis prescription. This weight loss was attributed to uremic anorexia secondary to inadequate dialysis. Cases of CAPD patients developing weight loss after loss of residual renal function and regaining weight after an increase in the dose of peritoneal dialysis have been reported. 38 The contribution of inadequate clearances to weight deficit in peritoneal dialysis populations has not been studied adequately, however. Fox et al 39 reported an average loss of 10% of body weight during episodes of persistent peritonitis. The extent of contribution of severe catheter-related infections to the development of weight deficit in peritoneal dialysis populations has not been studied adequately.
Theoretically the best way to study the effect of underdialysis on the development of weight deficit in CAPD would be a prospective study. Such a study will not, and should not, be done in the era of the DOQI guidelines, however. Retrospective analyses, such as the present study, may not provide all the answers because they often miss important information or are not controlled for some important factors. For example, we were unable to trace body weight measurements to the initiation of CAPD in all the underweight subjects in the present study. The time on CAPD until the first clearance study, although not different statistically between the groups and subgroups compared, varied greatly between indi-vidual patients. Despite these drawbacks, this study provided information shedding some light on the relationship between underdialysis and malnutrition in CAPD.
The purpose of the present study was to analyze the relationship between small solute clearances, nutrition indices, and weight deficit in CAPD. The higher frequency of high peritoneal transport in the underweight group probably is explained by the higher frequency of malnutrition, whether it is caused by chronic inflammatory syndrome or not, in high transporters. 40 In general, patients with weight deficit had worse nutrition indices than those with normal weight (Tables 2, 5 , and 6). Nutrition indices calculated from urea nitrogen excretion may have overestimated dietary protein intake in the underweight group because of the presence of catabolic states in many patients in this group. 41 The normalization process also could have caused artificially elevated normalized nutrition indices (PNA, LBM) in the underweight group. The underweight group had a relatively high level of indices normalized to actual body size (nPNA W , LBM/W). This misleading finding is caused by the low values of the normalizing size indicators in underweight individuals. 42 Normalization of the same indices by a size indicator reflecting the metabolic needs of underweight patients provides a more accurate picture of nutrition in these subjects. 43 In this report, we used ideal weight as the proper size indicator.
Comparison of the clearances revealed no differences in mean Kt/V urea and creatinine clearance between the underweight and normalweight groups (Table 3) . Kt/V urea and creatinine clearance values calculated using actual weight to estimate the normalizing parameters V and BSA were higher in underweight than in normalweight subjects with adequate Kt/V urea (Table  4) . Kt/V urea calculated with the use of actual weight to estimate V was higher in underweight than in normal-weight patients with inadequate Kt/V urea (Table 5 ). These differences were caused by the low values of the normalizing parameters V and BSA in underweight CAPD subjects. The differences disappeared when the clearances were normalized by V and BSA calculated by the use of ideal weight, instead of actual weight, in the Watson and Dubois formulae. Raw clearances of urea and creatinine were almost identical between subgroups IA and IIA (Table  5 ) and between subgroups IB and IIB (Table 5) . The percent of subjects with adequate clearances at the first clearance study after initiation of CAPD was similar between the groups despite the fact that adequate clearance levels, set according to K/DOQI guidelines, 24 were substantially higher in the underweight group, and the percent of anuric subjects was similar between the groups. Consequently, differences in small solute clearances did not exist between underweight and normal-weight patients in this study.
We traced weight measurements in many underweight individuals throughout the CAPD period and in some even earlier. Most patients had low weight at initiation of CAPD. Uremia before the start of CAPD could have contributed to this weight loss. Many patients had chronic catabolic states and progressive weight losses starting before the initiation of CAPD. Approximately 40% of the underweight patients had adequate clearances. In these patients, the causes of weight deficit were catabolic illness and, probably, uremia before the initiation of CAPD but not inadequate clearances during CAPD. We cannot eliminate a possible contribution of inadequate clearances during the course of CAPD to the maintenance of weight deficit in the remaining 60% of the underweight subjects. Most patients in this subgroup started CAPD with weight deficit, and many had catabolic illness and progressive weight loss before starting CAPD. It seems that catabolic illness was the major cause of weight deficit in these patients also.
Despite the absence of convincing evidence linking the development of weight deficit to underdialysis in CAPD, several nutrition indices, including serum creatinine, PNA, nPNA, LBM/W, and LBM/IW, but not serum albumin, were substantially worse in underdialyzed than adequately dialyzed underweight CAPD patients ( Table 6 ). The differences in PNA and nPNA should be interpreted with caution, in view of the mathematical linkage between PNA and Kt/V urea in cross-sectional CAPD studies. 44 Nevertheless, it seems that although the comparison between the underdialyzed and adequately dialyzed subgroups (Tables 4-6) did not clarify the effect of underdialysis on the development of weight deficit in CAPD, it provided evidence that underdialysis is associated with more severe malnutrition in underweight CAPD patients.
In underweight patients gaining weight in the course of CAPD, Kt/V urea, but not creatinine clearance, values were higher than the K/DOQI standards, whereas in underweight patients losing weight, Kt/V urea values were lower than the K/DOQI standards ( Table 7) . The patients who gained weight were younger and predominantly women. The gender difference between the underweight and normal-weight groups may explain the difference between Kt/V urea and creatinine clearance. The ratio V/BSA is much lower in women than in men. 45, 46 A consequence of normalizing urea clearance by V and creatinine clearance by BSA is that women on CAPD tend to have higher Kt/V urea than men, even when the men have higher creatinine clearance. 47 Normalization of creatinine clearance by V instead of BSA eliminates the gender difference in creatinine clearance. 47 The findings in Table 7 suggest that young underweight patients on CAPD with adequate, by K/DOQI standards, Kt/V urea can gain weight, whereas patients with inadequate Kt/V urea may lose weight. These findings should be interpreted with great caution, however. The number of underweight subjects gaining weight was too small, and a type I statistical error could be probable. In addition, the patients who lost weight had inadequate clearances and severe catabolic illnesses. The high death rate in underweight patients losing weight is notable. This finding seems to confirm previous reports. 31 We did not have sufficient data to perform a formal survival analysis, however.
